Orthopedic Regenerative Surgical Products Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 4.30 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Orthopedic Regenerative Surgical Products Market Analysis
The orthopedic regenerative surgical products market studied is expected to grow with an estimated CAGR of 4.3%, over the forecast period.
The COVID-19 pandemic is expected to have an impact on the orthopedic regenerative surgical products market owing to the disruptions in clinical studies, cancellation of elective procedures, and supply chain disruption. Orthopedic regenerative surgical products suppliers faced several challenges such as travel restrictions, business closures, stay-at-home protocols, and employee illness or quarantines during the pandemic.
A large number of hospitals have canceled or postponed elective surgeries across the world to prevent cross-infection and meet the demands of coronavirus patients. For instance, University Medical Center and Sunrise Health in Las Vegas postponed elective surgeries to save bed capacity in 2020. According to the CovidSurg Collaborative in 2020, orthopedic procedures were canceled most frequently, composing 26% of the total cancelled or postponed surgeries in 2020, which had a short-term negative impact on the market.
Certain factors that are driving the market growth include the rising prevalence of arthritis and other orthopedic conditions and growing technological advancements. According to data published by the Centers for Disease Control and Prevention in 2018, an estimated 54.4 million adults had doctor-diagnosed arthritis, with significantly higher prevalence in women than in men in the United States. In addition, according to the Centers for Disease Control and Prevention estimates about 78.4 million (25.9% of the projected total adult population) adults aged 18 years and older will have doctor-diagnosed arthritis by 2040.
Furthermore, with increase in geriatric population, there is rise in number of people suffering from orthopedic conditions requiring regenerative treatment. Also, utilization of emerging technologies including platelet rich plasma (PRP) therapies, viscosupplements, and stem cells is increased in the healthcare industry. The above-mentioned statistics indicate that the prevalence of arthritis and demand for orthopedic regenerative surgical products are increasing, which may drive market over the forecast period. However, factors such as poor reimbursement scenarios and stringent regulatory scenarios may hamper the growth of the market.
Orthopedic Regenerative Surgical Products Market Trends
This section covers the major market trends shaping the Orthopedic Regenerative Surgical Products Market according to our research experts:
Viscosupplements is Expected to Hold a Significant Share Over the Forecast Period
Viscosupplements are the injection of hyaluronic acid which injects into diarthrodial joints, intending to restore the rheological properties of the synovial fluid, thereby producing analgesic, mechanical, chondroprotective, and anti-inflammatory effects. Viscosupplements are usually preferred by healthcare providers to treat osteoarthritis, but then it may also benefit patients with certain other kinds of arthritis, such as rheumatoid arthritis.
An increase in the incidence of knee pain and osteoarthritis is expected to drive the viscosupplements segment growth over the forecast period. According to the Statistics Canada in 2021, approximately 5.9 million adult Canadians had arthritis in 2020. The prevalence of arthritis increases with age and is higher among females.
Furthermore, obesity is another risk factor contributing to orthopedic conditions. According to the World Health Organization in 2021, about 13% of the world's adult population were obese in 2016 and 38.2 million children under the age of 5 years were overweight in 2019. Based on the above-mentioned facts, it is expected that the viscosupplements segment will augment over the forecast period.
North America Dominates the Market and is Expected to do the Same in the Forecast Period
North America holds the major market share in the orthopedic regenerative surgical products market and is expected to dominate the overall market, throughout the forecast period owing to the increasing incidences of orthopedic conditions, growing geriatric population, and high adoption of regenerative orthopedics in the region. In the North America region, the United States is slated to be the largest market due to the presence of a large number of orthopedic regenerative surgical products manufacturers and suppliers. In addition, According to United States Census Bureau, there were 54.1 million United States residents 65 years and older in July 2019. Furthermore, high awareness of orthopedic regenerative surgical products and high prevalence of arthritis joint pain with other co-occurring conditions such as diabetes among adults in the United States has led North America to witness tremendous growth in the orthopedic regenerative surgical products market. For instance, severe joint pain is more common among adults with arthritis with other chronic conditions such as heart disease (34.1%), diabetes (40.9%), disability (45.6%), obesity (31.7%), and psychological distress (56.3%).
Furthermore, adoption of mergers and acquisitions and partnerships as a key growth strategy by regional companies is anticipated to further propel market over the forecast period. For instance, on 6 May 2021, MIMEDX Group, Inc. and the Wake Forest Institute for Regenerative Medicine announced a collaborative agreement to advance regenerative science and innovative biologics.
Orthopedic Regenerative Surgical Products Industry Overview
The orthopedic regenerative surgical products market is highly competitive in nature with several players across globe. Companies, like Zimmer Biomet, Stryker, AlloSource, Amniox Medical, Inc., Anika Therapeutics, Inc., Smith & Nephew, Baxter, Vericel Corporation, MIMEDX, and Aptissen S.A, among others, hold the substantial market share in the market studied.
Orthopedic Regenerative Surgical Products Market Leaders
-
Zimmer Biomet
-
Stryker
-
AlloSource
-
Amniox Medical, Inc.
-
Anika Therapeutics, Inc.
*Disclaimer: Major Players sorted in no particular order
Orthopedic Regenerative Surgical Products Market News
In August 2021, SEIKAGAKU CORPORATION launched the HyLink, an intra-articular single injection viscosupplement in Taiwan. The new product was launched through TCM Biotech International Corp. for the treatment of knee osteoarthritis.
In January 2021, Miravo Healthcare announced the commercial launch of NeoVisc+ and NeoVisc ONE in Canada. These are hyaluronic acid Viscosupplements developed for the treatment of pain. NeoVisc+ and NeoVisc ONE received Health Canada approval in September 2020.
Orthopedic Regenerative Surgical Products Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in the Prevalence of Orthopedic Diseases
4.2.2 Increasing Geriatric Population
4.2.3 Technological Advancements in the Products
4.3 Market Restraints
4.3.1 High Cost of Products
4.3.2 Stringent Regulatory Scenario
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Product
5.1.1 Allograft
5.1.2 Cell-based
5.1.3 Viscosupplements
5.2 By Applications
5.2.1 Orthopedic Pain Management
5.2.2 Trauma Repair
5.2.3 Cartilage and Tendon Repair
5.2.4 Joint Reconstruction
5.2.5 Others
5.3 By End-User
5.3.1 Hospitals
5.3.2 Ambulatory Surgical Centers
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Zimmer Biomet
6.1.2 Stryker
6.1.3 AlloSource
6.1.4 Amniox Medical, Inc.
6.1.5 Anika Therapeutics, Inc.
6.1.6 Smith & Nephew
6.1.7 Baxter
6.1.8 Vericel Corporation
6.1.9 MIMEDX
6.1.10 Aptissen S.A
6.1.11 Arthrex, Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Orthopedic Regenerative Surgical Products Industry Segmentation
Regenerative orthopedics helps to treat discomfort and pain of the musculoskeletal system and improve the healing of orthopedic conditions, such as ligament, injuries of a tendon, muscle, bone, meniscus of the knee, spinal disc, and cartilage. These body parts have a comparatively poor capability to heal on their own. Regenerative orthopedic surgical products help these tissues to heal better. Orthopedic regenerative surgical products may help some patients avoid orthopedic surgery completely.
The orthopedic regenerative surgical products market is segmented by Product (Allograft, Cell-based, and Viscosupplements), Application (Orthopedic Pain Management, Trauma Repair, Cartilage and Tendon Repair, Joint Reconstruction, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.
| By Product | |
| Allograft | |
| Cell-based | |
| Viscosupplements |
| By Applications | |
| Orthopedic Pain Management | |
| Trauma Repair | |
| Cartilage and Tendon Repair | |
| Joint Reconstruction | |
| Others |
| By End-User | |
| Hospitals | |
| Ambulatory Surgical Centers | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Orthopedic Regenerative Surgical Products Market Research FAQs
What is the current Global Orthopedic Regenerative Surgical Products Market size?
The Global Orthopedic Regenerative Surgical Products Market is projected to register a CAGR of 4.30% during the forecast period (2024-2029)
Who are the key players in Global Orthopedic Regenerative Surgical Products Market?
Zimmer Biomet, Stryker , AlloSource , Amniox Medical, Inc. and Anika Therapeutics, Inc. are the major companies operating in the Global Orthopedic Regenerative Surgical Products Market.
Which is the fastest growing region in Global Orthopedic Regenerative Surgical Products Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Orthopedic Regenerative Surgical Products Market?
In 2024, the North America accounts for the largest market share in Global Orthopedic Regenerative Surgical Products Market.
What years does this Global Orthopedic Regenerative Surgical Products Market cover?
The report covers the Global Orthopedic Regenerative Surgical Products Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Orthopedic Regenerative Surgical Products Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Global Orthopedic Regenerative Surgical Products Industry Report
Statistics for the 2024 Global Orthopedic Regenerative Surgical Products market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Global Orthopedic Regenerative Surgical Products analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
